Pacific Biosciences of CaliforniaPACB
那斯達克 · USD
1.45
-0.18
(-11.04%)
收盤 06/06 03:59 (UTC+8)
06/06 03:59 (UTC+8)
Pacific Biosciences of CaliforniaPACB
1.45
-0.18
(-11.04%)
財務數據
損益表
- 0.58
- 0.39
- 0.36
- 0.40
- 0.39
- 0.37
- 0.40
- 0.38
- 0.45
- 0.37
- 4.79
- -33.50
- -7.21
- 10.98
- -1.86
- -5.28
- 7.03
- -3.33
- 16.14
- -16.73
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 37,178 | 44,645 | 38,441 | 39,766 | 37,153 | 39,224 | 39,967 | 36,013 | 38,810 | 58,357 |
營業成本 | 24,337 | 28,079 | 22,540 | 25,082 | 38,524 | 29,166 | 29,963 | 30,075 | 27,528 | 48,786 |
營業毛利 | 12,841 | 16,566 | 15,901 | 14,684 | -1,371 | 10,058 | 10,004 | 5,938 | 11,282 | 9,571 |
營業費用 | 66,994 | 57,763 | 54,778 | 59,537 | 427,563 | 163,086 | 74,081 | 181,784 | 92,644 | 97,119 |
研發費用 | 19,608 | 22,879 | 22,846 | 22,529 | 29,053 | 27,466 | 25,516 | 38,485 | 43,455 | 44,544 |
推銷及管理費用 | 46,553 | 34,051 | 31,099 | 36,175 | 21,468 | 39,691 | 44,916 | 45,877 | 43,683 | 47,096 |
非經常性項目費用 | - | - | - | - | 15,000 | 91,300 | - | 93,200 | - | 63 |
其他營業費用 | 833 | 833 | 833 | 833 | 362,042 | 4,629 | 3,649 | 4,222 | 5,506 | 5,416 |
營業利益 | -8,357 | -41,197 | -38,877 | -44,853 | -428,934 | -153,028 | -64,077 | -175,846 | -81,362 | -87,548 |
其他收入及費用 | 47,802 | 2,768 | 2,999 | 4,696 | 4,294 | 158,472 | 6,890 | 6,069 | 6,759 | 8,383 |
利息費用 | 1,740 | 1,740 | 1,739 | 1,738 | 1,737 | 2,757 | 3,538 | 3,542 | 3,575 | 3,571 |
稅前純益 | -8,091 | -40,169 | -37,617 | -41,895 | -426,377 | 2,687 | -60,725 | -173,319 | -78,178 | -82,736 |
所得稅 | 184 | 202 | 383 | 35 | -302 | 316 | - | - | - | -718 |
稅後純益 | -8,275 | -40,371 | -38,000 | -41,930 | -426,075 | 2,371 | -60,725 | -173,319 | -78,178 | -82,018 |
基本每股稅後盈餘(元) | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 | 0.01 | -0.22 | -0.64 | -0.29 | -0.31 |
稀釋每股稅後盈餘(元) | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 | -0.44 | -0.22 | -0.64 | -0.29 | -0.31 |
基本平均股數(千股) | 305819.00 | 301907.00 | 300844.00 | 300162.00 | 296858.00 | 282999.00 | 272915.00 | 272385.00 | 296858.00 | 267121.00 |
稀釋平均股數(千股) | 305819.00 | 301907.00 | 300844.00 | 300162.00 | 296858.00 | 306892.00 | 272915.00 | 272385.00 | 296858.00 | 267121.00 |
還原基本每股稅後盈餘(元) | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 | 0.01 | -0.22 | -0.64 | -0.29 | -0.31 |
還原稀釋每股稅後盈餘(元) | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 | -0.44 | -0.22 | -0.64 | -0.29 | -0.31 |
還原基本平均股數(千股) | 305,819 | 301,907 | 300,844 | 300,162 | 296,858 | 282,999 | 272,915 | 272,385 | 296,858 | 267,121 |
還原稀釋平均股數(千股) | 305,819 | 301,907 | 300,844 | 300,162 | 296,858 | 306,892 | 272,915 | 272,385 | 296,858 | 267,121 |
EBITDA(千元) | -2,577 | -34,240 | -32,399 | -36,851 | -53,567 | 14,012 | -44,179 | -159,029 | -66,620 | -70,218 |